Tumor cells PD-L1 expression as a favorable prognosis factor in nasopharyngeal carcinoma patients with pre-existing intratumor-infiltrating lymphocytes-Reference-Cited by-同舟云学术

Tumor cells PD-L1 expression as a favorable prognosis factor in nasopharyngeal carcinoma patients with pre-existing intratumor-infiltrating lymphocytes

Published:2017-05-04 Issue:5 Volume:6 Page:e1312240
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Zhu Qian¹²,Cai Mu-Yan¹³,Chen Chang-Long¹²,Hu Hao⁴,Lin Huan-Xin¹⁵,Li Min¹³,Weng De-Sheng¹²,Zhao Jing-Jing¹²,Guo Ling¹⁶,Xia Jian-Chuan¹²

Affiliation:

1. Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China

2. Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China

3. Department of Pathology, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China

4. Department of Thoracic Surgery, Medical College of Nanchang University, Nanchang, People's Republic of China

5. Department of Radiotherapy, Sun Yat-Sen University Cancer Center, Guangzhou , People's Republic of China

6. Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2017.1312240

Reference42 articles.

1. The Enigmatic Epidemiology of Nasopharyngeal Carcinoma

2. The prevalence and prevention of nasopharyngeal carcinoma in China

3. Current treatment options for recurrent nasopharyngeal cancer

4. The battle against nasopharyngeal cancer

5. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of cadonilimab in previously treated recurrent or metastatic nasopharyngeal carcinoma(COMPASSION-06): A phase II multicenter study;Oral Oncology;2024-04

2. A novel model for predicting prognosis and response to immunotherapy in nasopharyngeal carcinoma patients;Cancer Immunology, Immunotherapy;2024-01

3. Recent Advances in Assessing the Clinical Implications of Epstein-Barr Virus Infection and Their Application to the Diagnosis and Treatment of Nasopharyngeal Carcinoma;Microorganisms;2023-12-20

4. Efficacy and safety of PD-1 inhibitors in recurrent or metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens: a systematic review and meta-analysis;BMC Cancer;2023-11-30

5. A case report and literature review on reactive cutaneous capillary endothelial proliferation induced by camrelizumab in a nasopharyngeal carcinoma patient;Frontiers in Oncology;2023-11-28